Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2026 - 31.03.2027

DAK-Gesundheit · Deadline not specified

Buyer
DAK-Gesundheit
Status
Deadline not specified
Country
EU
Region
EU - Western Europe
Sector
IT & Technology
Reference
TED-569497-2026
Published
2026-09-17

Tender summary

competition. Please refer to TED for full details.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap